Regulation of HMG-CoA reductase expression by hypoxia

Journal of Cellular Biochemistry

Volumn 104, Issue 3, 2008, Pages 701-709

  Pallottini, Valentina ^a   Guantario, Barbara ^a   Martini, Chiara ^a   Totta, Pierangela ^b   Filippi, Irene ^c   Carraro, Fabio ^c   Trentalance, Anna ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

HepG2; HIF 1 ; HMG CoAR; Hypoxia; SCAP

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

ARTICLE; CELL NUCLEUS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPOXIA; METABOLISM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANOXIA; CELL LINE; CELL NUCLEUS; CHOLESTEROL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MODELS, BIOLOGICAL; OXYGEN; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; TIME FACTORS; TRANSCRIPTION, GENETIC;

INVERTEBRATA; VERTEBRATA;

EID: 45149095195     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21757     Document Type: Article

References (30)

1. DeBose-Boyd RA, Brown MS, Li WP, Nohturfft A, Goldstein JL, Espenshade PJ. 1999. Transport-dependent proteolysis of SREBP: Relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi. Cell 99:703-712.
2. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
3. Gil G, Faust JR, Chin DJ, Goldstein JL, Brown MS. 1985. Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme. Cell 41:249-258.
4. Goldstein JL, DeBose-Boyd RA, Brown MS. 2006. Protein sensors for membrane sterols. Cell 124:35-46.
5. Harris AL. 2002. Hypoxia - A key regulatory factor in tumour growth. Nat Rev Cancer 2:38-47.
6. Hirota K, Semenza GL. 2006. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59:15-26.
7. Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131.
8. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-7992.
9. Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, Smith PL, O'Donnell CP, Polotsky VY. 2005a. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99:1643-1648.
10. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, Marino RL, Rodriguez A, Hubbard WC, O'Donnell CP, Polotsky VY. 2005b. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97:698-706.
11. Liscum L, Finer-Moore J, Stroud RM, Luskey KL, Brown MS, Goldstein JL. 1985. Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum. J Biol Chem 260:522-530.
12. Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, Krek W. 1999. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev 13:1822-1833.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
14. Mahon PC, Hirota K, Semenza GL. 2001. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15:2675-2686.
15. Mukodani J, Ishikawa Y, Fukuzaki H. 1990. Effects of hypoxia on sterol synthesis, acyl-CoA:cholesterol acyltransferase activity, and efflux of cholesterol in cultured rabbit skin fibroblasts. Arteriosclerosis 10:106-110.
16. Nguyen AD, McDonald JG, Bruick RK, DeBose-Boyd RA. 2007. Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of Insigs. J Biol Chem 282:27436-27446.
17. Nohturfft A, DeBose-Boyd RA, Scheek S, Goldstein JL, Brown MS. 1999. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc Natl Acad Sci USA 96:11235-11240.
18. Pallottini V, Martini C, Pascolini A, Cavallini G, Gori Z, Bergamini E, Incerpi S, Trentalance A. 2005. 3-Hydroxy-3-methylglutaryl coenzyme A reductase deregulation and age-related hypercholesterolemia: A new role for ROS. Mech Ageing Dev 126:845-851.
19. Patiar S, Harris AL. 2006. Role of hypoxia-inducible factor-1alpha as a cancer therapy target. Endocr Relat Cancer 13 (Suppl 1):S61-S75.
20. Rawson RB, DeBose-Boyd R, Goldstein JL, Brown MS. 1999. Failure to cleave sterol regulatory element-binding proteins (SREBPs) causes cholesterol auxotrophy in Chinese hamster ovary cells with genetic absence of SREBP cleavage-activating protein. J Biol Chem 274:28549-28556.
21. Robichon C, Dugail I. 2007. De novo cholesterol synthesis at the crossroads of adaptive response to extracellular stress through SREBP. Biochimie 89:260-264.
22. Semenza GL. 2001. Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345-350.
23. Semenza GL. 2006. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 91:803-806.
24. Sever N, Yang T, Brown MS, Goldstein JL, DeBose-Boyd RA. 2003. Accelerated degradation of HMG CoA reductase mediated by binding of Insig-1 to its sterol-sensing domain. Mol Cell 11:25-33.
25. Sun HL, Liu YN, Huang YT, Pan SL, Huang DY, Guh JH, Lee FY, Kuo SC, Teng CM. 2007. YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 26:3941-3951.
26. 2 tension. Proc Natl Acad Sci 92:5510-5514.
27. Yamashita K, Discher DJ, Hu J, Bishopric NH, Webster KA. 2001. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem 276:12645-12653.
28. Yeh WL, Lu DY, Lin CJ, Liou HC, Fu WM. 2007. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol Pharmacol 72:440-449.
29. Zager RA, Johnson AC, Naito M, Bomsztyk K. 2007. Maleate Nephrotoxicity: Mechanisms of injury and correlates with ischemic/hypoxic tubular cell death. Am J Physiol Renal Physiol 294:F187-F197.
30. Zhao Q, Du J, Gu H, Teng X, Zhang Q, Qin H, Liu N. 2008. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Pancreas 34:242-247.